Vericel (VCEL) Inventory Average (2014 - 2026)
Vericel (VCEL) reported Inventory Average of $18.0 million for Q1 2026, up 4.15% on a YoY basis from $17.2 million in Q1 2025, and up 0.55% sequentially from $17.9 million in Q4 2025.
Vericel (VCEL) Inventory Average (2014 - 2026) Analysis & Trends
Vericel (VCEL) has 13 years of Inventory Average data on file, last reported at $18.0 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 4.15% year-over-year to $18.0 million; the trailing twelve-month figure through Mar 2026 stood at $18.0 million (up 4.15% YoY), and the FY2025 full-year result was $17.5 million, up 14.68% from the prior year.
- Inventory Average rose to $18.0 million in Q1 2026, from $17.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $18.0 million in Q1 2026 to a low of $12.9 million in Q4 2023.
- A 5-year average of $15.6 million and a median of $15.7 million in 2023 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average soared 41.1% in 2022 and slipped 21.42% in 2023, its largest moves.
- Tracing VCEL's Inventory Average over 5 years: stood at $16.4 million in 2022, then declined by 21.42% to $12.9 million in 2023, then increased by 28.87% to $16.6 million in 2024, then rose by 7.81% to $17.9 million in 2025, then gained by 0.55% to $18.0 million in 2026.
- Business Quant data shows VCEL's Inventory Average at $18.0 million in Q1 2026, $17.9 million in Q4 2025, and $17.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 17.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.96 Mn |
| Dec 31, 2025 | 17.86 Mn |
| Sep 30, 2025 | 17.49 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Mar 31, 2025 | 17.24 Mn |
| Dec 31, 2024 | 16.56 Mn |
| Sep 30, 2024 | 15.32 Mn |
| Jun 30, 2024 | 14.22 Mn |
| Mar 31, 2024 | 13.32 Mn |
| Dec 31, 2023 | 12.85 Mn |
| Sep 30, 2023 | 13.25 Mn |
| Jun 30, 2023 | 14.63 Mn |
| Mar 31, 2023 | 15.68 Mn |
| Dec 31, 2022 | 16.36 Mn |
| Sep 30, 2022 | 16.33 Mn |
| Jun 30, 2022 | 15.16 Mn |
| Mar 31, 2022 | 13.88 Mn |
| Dec 31, 2021 | 13.22 Mn |
| Sep 30, 2021 | 13.01 Mn |
| Jun 30, 2021 | 11.64 Mn |